Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia

Ali McBride; Kim Campbell; Mohan Bikkina; Karen MacDonald; Ivo Abraham; Sanjeev Balu

doi:10.1080/13696998.2017.1358173

Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia

Journal of Medical Economics ◽

10.1080/13696998.2017.1358173 ◽

2017 ◽

Vol 20 (10) ◽

pp. 1083-1093 ◽

Cited By ~ 14

Author(s):

Ali McBride ◽

Kim Campbell ◽

Mohan Bikkina ◽

Karen MacDonald ◽

Ivo Abraham ◽

...

Keyword(s):

Febrile Neutropenia ◽

Cost Efficiency ◽

The Us ◽

Biosimilar Filgrastim

Download Full-text

Response to: McBride A, Campbell K, Bikkina M, et al. Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia. J Med Econ 2017;20:1083–93

Journal of Medical Economics ◽

10.1080/13696998.2018.1452747 ◽

2018 ◽

Vol 21 (6) ◽

pp. 603-605 ◽

Cited By ~ 1

Author(s):

Mark Bensink ◽

Christine Edwards ◽

Charles Bowers ◽

Jon Campbell

Keyword(s):

Febrile Neutropenia ◽

Cost Efficiency ◽

The Us ◽

Biosimilar Filgrastim

Download Full-text

Reply: Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia

Journal of Medical Economics ◽

10.1080/13696998.2018.1452749 ◽

2018 ◽

Vol 21 (6) ◽

pp. 606-609 ◽

Cited By ~ 3

Author(s):

Ali McBride ◽

Kim Campbell ◽

Mohan Bikkina ◽

Karen MacDonald ◽

Ivo Abraham ◽

...

Keyword(s):

Febrile Neutropenia ◽

Cost Efficiency ◽

The Us ◽

Biosimilar Filgrastim

Download Full-text

Cost simulation for the US of febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim in lung cancer

Annals of Oncology ◽

10.1093/annonc/mdy444.017 ◽

2018 ◽

Vol 29 ◽

pp. ix133-ix134

Author(s):

A. McBride ◽

A. Krendyukov ◽

N. Mathieson ◽

K. Campbell ◽

S. Balu ◽

...

Keyword(s):

Lung Cancer ◽

Febrile Neutropenia ◽

Single Injection ◽

The Us ◽

Cost Simulation ◽

Biosimilar Filgrastim

Download Full-text

Comparative cost-efficiency across the European G5 countries of various regimens of filgrastim, biosimilar filgrastim, and pegfilgrastim to reduce the incidence of chemotherapy-induced febrile neutropenia

Journal of Oncology Pharmacy Practice ◽

10.1177/1078155211407367 ◽

2011 ◽

Vol 18 (2) ◽

pp. 171-179 ◽

Cited By ~ 58

Author(s):

Matti Aapro ◽

Paul Cornes ◽

Ivo Abraham

Keyword(s):

Febrile Neutropenia ◽

Cost Efficiency ◽

Comparative Cost ◽

Biosimilar Filgrastim

Download Full-text

Cost-efficiency and expanded access of prophylaxis for chemotherapy-induced (febrile) neutropenia: economic simulation analysis for the US of conversion from reference pegfilgrastim to biosimilar pegfilgrastim-cbqv

Journal of Medical Economics ◽

10.1080/13696998.2020.1833339 ◽

2020 ◽

pp. 1-11

Author(s):

Karen MacDonald ◽

Ali McBride ◽

Neda Alrawashdh ◽

Ivo Abraham

Keyword(s):

Febrile Neutropenia ◽

Cost Efficiency ◽

Simulation Analysis ◽

Expanded Access ◽

The Us ◽

Economic Simulation

Download Full-text

Cost efficiency in the US steel industry: A nonparametric analysis using data envelopment analysis

European Journal of Operational Research ◽

10.1016/0377-2217(94)00143-z ◽

1995 ◽

Vol 80 (3) ◽

pp. 654-671 ◽

Cited By ~ 21

Author(s):

Subhash C. Ray ◽

Hiung Joon Kim

Keyword(s):

Data Envelopment Analysis ◽

Steel Industry ◽

Cost Efficiency ◽

Nonparametric Analysis ◽

Data Envelopment ◽

The Us ◽

Using Data

Download Full-text

Update on the MONITOR-GCSF study of biosimilar filgrastim to reduce the incidence of chemotherapy-induced febrile neutropenia in cancer patients: Protocol amendments

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2011.01.006 ◽

2011 ◽

Vol 77 (3) ◽

pp. 198-200 ◽

Cited By ~ 13

Author(s):

Pere Gascón ◽

Matti Aapro ◽

Heinz Ludwig ◽

Nadia Rosencher ◽

M. Boccadoro ◽

...

Keyword(s):

Febrile Neutropenia ◽

Cancer Patients ◽

Biosimilar Filgrastim

Download Full-text

Cost efficiency and scale economies in general dental practices in the US: a non-parametric and parametric analysis of Colorado data

Journal of the Operational Research Society ◽

10.1057/jors.2011.109 ◽

2013 ◽

Vol 64 (5) ◽

pp. 762-774 ◽

Cited By ~ 1

Author(s):

L Chen ◽

S C Ray

Keyword(s):

Cost Efficiency ◽

Parametric Analysis ◽

Scale Economies ◽

The Us ◽

Dental Practices ◽

Non Parametric

Download Full-text

1596 Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia (CIN/FN) prophylaxis with biosimilar filgrastim and development of an outcomes risk calculator (MONITOR-GCSF study)

European Journal of Cancer ◽

10.1016/s0959-8049(16)30684-0 ◽

2015 ◽

Vol 51 ◽

pp. S236

Author(s):

M. Aapro ◽

H. Ludwig ◽

C. Bokemeyer ◽

P. Gascón ◽

M. Boccadoro ◽

...

Keyword(s):

Febrile Neutropenia ◽

Predictive Modeling ◽

Risk Calculator ◽

Biosimilar Filgrastim

Download Full-text

Febrile neutropenia costly in the US

PharmacoEconomics & Outcomes News ◽

10.2165/00151234-201206610-00021 ◽

2012 ◽

Vol 661 (1) ◽

pp. 8-8

Keyword(s):

Febrile Neutropenia ◽

The Us

Download Full-text